戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 following transplantation did not prevent BK viruria.
2  JCV seronegative patients, 10 (37%) had JCV viruria.
3  BK viremia and after no intervention for JC viruria.
4 les from renal allograft recipients with BKV viruria.
5 ositive cytology compared with those without viruria.
6 re associated with a higher frequency of BKV viruria.
7 g BK viremia (0.161 vs. 0.065, P=0.0378) and viruria (0.303 vs. 0.146, P=0.0067) compared with Group
8 both viremia (0.297 vs. 0.261, P=0.6061) and viruria (0.437 vs. 0.389, P=0.5363).
9 equent in putative rejection with concurrent viruria (48.6%), compared with rejection before (9.1%) o
10     Ninety-five (40%) patients had sustained viruria, 48 (20%) sustained viremia, and 17 (7%) biopsy-
11 V viruria was far more common (37%) than BKV viruria (5%) in HIV-seronegative persons.
12     Of 666 recipients, 250 (37.5%) developed viruria, 80 (12%) developed viremia and 31 (4.7%) develo
13 ing of urinary Haufen and not BK viremia and viruria accurately mark BK polyomavirus nephropathy.
14 omavirus BK (BKV) infection characterized by viruria alone is considered to be of little clinical sig
15                       Among these, 33 had BK viruria alone, 61 had BK viremia with viruria and 25 had
16 itis is far less frequent than BK viremia or viruria, analysis of risk factors for BKV nephritis as a
17 had BK viruria alone, 61 had BK viremia with viruria and 25 had significant viremia defined as BKV DN
18                                              Viruria and DNAemia patterns were investigated in 205 se
19 a significant risk factor for posttransplant viruria and viremia (OR, 4.52; CI, 2.33-8.77; P < 0.0001
20 ents with BKV nephropathy than in those with viruria and viremia (P = 0.045).
21 or the occurrence of BKV infections using BK viruria and viremia as endpoints.
22 comparing the results of JCV serology to JCV viruria and viremia in 67 patients enrolled in a single-
23                                           BK viruria and viremia resolved after cessation of IS and n
24                                 Intermittent viruria and viremia was observed throughout the study.
25  statistics showed fair to good agreement of viruria and viremia with BK polyomavirus nephropathy or
26  BKV positive earlier than in the group with viruria and viremia.
27  may act as the source of virus resulting in viruria and viremia.
28                One patient with asymptomatic viruria and with a viral load overlapping values seen in
29 l reactivation occurs first in the urine (BK viruria) and is associated with a high risk of transplan
30             At baseline, 39% of patients had viruria, and 24% had DNAemia.
31 ive and specific, but periods of viremia and viruria are brief, limiting the utility of ZIKV RNA assa
32 In young seropositive women, CMV DNAemia and viruria are common, which suggests that naturally acquir
33 e planned follow-up period or development of viruria because the trial was stopped early owing to lac
34 hain reaction or in longitudinal DNAemia and viruria between the women with and without serological e
35 fter platelet engraftment with documented BK viruria [BK-HC]) were compared with matched controls.
36 nflammation and tubulitis in the presence of viruria but negative for BKV stains were designated as p
37 igher in renal allograft recipients with BKV viruria, but 58 (50.4%) of 115 renal biopsy samples test
38  Twenty-four women (9.2%) had detectable CMV viruria by qualitative PCR.
39                                              Viruria clearance was infrequent (15.6%).
40 sing decoy cells as a marker of polyomavirus viruria cytology has a sensitivity of 41.9% and negative
41 thology in concomitant renal biopsies and BK viruria (decoy cell shedding and viral load assessments
42 primary outcome was time to occurrence of BK viruria (detected using quantitative real-time polymeras
43 ains derived from patients with asymptomatic viruria did not show complete separation from strains as
44       We studied 230 patients with sustained viruria from whom multiple samples taken after a median
45 a greater than 5 x 103 copies/ml and with BK viruria greater than 107 copies/ml in all cases.
46                               Women with CMV viruria had significantly higher rates of HIV perinatal
47  also decreased the rates of CMV viremia and viruria, herpes simplex virus disease, and the use of in
48  settings: (i) patients with asymptomatic BK viruria, (ii) patients with active BKVAN, and (iii) pati
49 olymerase chain reaction (PCR) for detecting viruria in 100 urine samples.
50 assess their impact on JC and BK viremia and viruria in 15 healthy subjects, eight human immunodefici
51 ) viruria is more common than BK virus (BKV) viruria in healthy individuals but in kidney transplants
52 -five recipients (40%) had posttransplant BK viruria including 61 with additional viremia and 22 with
53 at intrarenal viral replication in sustained viruria is frequently associated with putative acute rej
54  immunosuppressed patients with polyomavirus viruria is largely supportive and directed toward minimi
55                               JC virus (JCV) viruria is more common than BK virus (BKV) viruria in he
56 he presence of BK viruria made concurrent JC viruria less likely: JC viruria was detected in 22% of n
57                In comparison, BK viremia and viruria levels by PCR showed only modest correlations wi
58 athy led to resolution of viremia, decreased viruria levels, and disappearance of viral inclusions, b
59                           The presence of BK viruria made concurrent JC viruria less likely: JC virur
60                             Compared with no viruria (n=515), sustained viruria was associated with m
61 pecificity and positive predictive value for viruria (not viral nephropathy) are 100%.
62                                           BK viruria occurred in 22 patients (29%) in the levofloxaci
63  polyomavirus reactivation (BK viremia or JC viruria) on antibodies to kidney-specific self-antigens
64 94 developed BKV infection (any degree of BK viruria or viremia) whereas 146 developed no infection.
65 cipient JC seropositivity did not predict BK viruria or viremia.
66  significantly higher incidence rates of BKV viruria, Pneumocystis jiroveci pneumonia, and malignancy
67 tive polymerase chain reaction [PCR]) and BK viruria (quantitative PCR and decoy cell counts).
68                                           BK viruria resolved within 4 to 12 weeks (after 1-4 doses)
69 reased; however, after cessation of therapy, viruria returned to near pretreatment levels.
70 lant recipients define levels of viremia and viruria that are actionable for additional testing or in
71                                        A BKV viruria threshold of >2.5E+07 copies/mL had 100% sensiti
72                          The incidence of BK viruria, viremia and nephropathy was not significantly d
73 -occurrence was 7.6, 7.9, and 9.7 months for viruria, viremia, and polyomavirus-associated nephropath
74           In this cross-sectional study, BKV viruria, viremia, and urinary decoy cells were detected
75 following kidney transplantation, leading to viruria, viremia, and, ultimately, PVAN, is associated w
76                  The overall incidence of JC viruria was 43 of 105 (40.9%) subjects, with a marked in
77                              The onset of JC viruria was associated with donor, but not recipient, JC
78  Compared with no viruria (n=515), sustained viruria was associated with more putative rejection epis
79 table renal transplant recipients with JCPyV viruria was attempted.
80  in biopsy specimens even for patients whose viruria was cleared.
81 a made concurrent JC viruria less likely: JC viruria was detected in 22% of non-BK viruric recipients
82                                          JCV viruria was far more common (37%) than BKV viruria (5%)
83 %) of 54 urines, 2-80 weeks after infection; viruria was less frequent after 6 months.
84                                 Maternal CMV viruria was not associated with mean CD4 cell counts or
85                             In summary, SV40 viruria was not detected among homosexual men who shed h
86                                          BKV viruria was strongly associated with BKV viremia (93%),
87                                          JCV viruria, was more often asymptomatic (P=0.002) and affec
88 re Haufen-negative, however, high viremia or viruria were detected in 8% and 41% of control samples,
89    Viral loads in patients with asymptomatic viruria were generally lower but in some cases overlappe
90         Women with detectable peripartum CMV viruria were more likely to have infants with cCMV than
91            Both baseline PCR viremia and PCR viruria were significantly associated with future cytome
92                                  JCV and BKV virurias were 46.7% and 0%, respectively.
93  of clinical presentations from asymptomatic viruria with pyuria to ureteral ulceration with ureteral
94  episodes (52.1%) occurred concurrently with viruria, with a minority before (7.8%) or after (40.1%)

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。